Patents by Inventor Mira Korpivaara

Mira Korpivaara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10780079
    Abstract: The invention relates to a method for alleviating noise aversion in animals, particularly dogs, comprising administering to a subject in need thereof an effective amount of dexmedetomidine, medetomidine or a pharmaceutically acceptable salt thereof as the active ingredient. The active ingredient is preferably administered oromucosally, e.g. in the form of an oromucosal gel.
    Type: Grant
    Filed: October 14, 2013
    Date of Patent: September 22, 2020
    Assignee: ORION CORPORATION
    Inventors: Johanna Kokkonen, Mira Korpivaara, Nina Sarén
  • Publication number: 20200069650
    Abstract: The invention relates to a method of treating separation anxiety in companion animals, particularly dogs, comprising administering to a subject in need thereof an effective amount of dexmedetomidine, medetomidine or a pharmaceutically acceptable salt thereof as the active ingredient. The active ingredient is preferably administered oromucosally, e.g. in the form of an oromucosal gel.
    Type: Application
    Filed: December 12, 2017
    Publication date: March 5, 2020
    Inventors: Mira KORPIVAARA, Sauli NIINISTÖ, Sanna ORMIO, Nina SARÉN
  • Publication number: 20150258067
    Abstract: The invention relates to a method for alleviating noise aversion in animals, particularly dogs, comprising administering to a subject in need thereof an effective amount of dexmedetomidine, medetomidine or a pharmaceutically acceptable salt thereof as the active ingredient. The active ingredient is preferably administered oromucosally, e.g. in the form of an oromucosal gel.
    Type: Application
    Filed: October 14, 2013
    Publication date: September 17, 2015
    Inventors: Johanna Kokkonen, Mira Korpivaara, Nina Sarén
  • Publication number: 20100286150
    Abstract: A method for the treatment of chronic valvular disease (CVD) in animals, particularly dogs, comprising administering to a subject in need thereof an effective amount of levosimendan or a pharmaceutically acceptable salt thereof. Levosimendan was shown to significantly reduce mortality and to significantly improve quality of life in dogs suffering from chronic valvular disease.
    Type: Application
    Filed: January 17, 2008
    Publication date: November 11, 2010
    Inventors: Fia Westerholm, Jouko Levijoki, Mira Korpivaara, Minna Leppänen